| CUSIX | VSIAX | CUSIX / VSIAX | |
| Total Expense Ratio | 1.00 | 0.07 | 1,429% |
| Annual Report Gross Expense Ratio | 4.22 | 0.07 | 6,029% |
| Fund Existence | 17 years | 15 years | - |
| Gain YTD | 6.679 | 12.719 | 53% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.45M | 65.5B | 0% |
| Annual Yield % from dividends | 1.04 | 1.76 | 59% |
| Returns for 1 year | 16.34 | 25.89 | 63% |
| Returns for 3 years | 13.29 | 46.10 | 29% |
| Returns for 5 years | -3.77 | 44.10 | -9% |
| Returns for 10 years | 30.72 | 136.53 | 23% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HJIRX | 20.20 | 0.34 | +1.71% |
| Hardman Johnston Intl Gr Fd Retl Shr | |||
| FADCX | 29.38 | 0.45 | +1.56% |
| Fidelity Advisor Diversified Intl C | |||
| FGSCX | 24.51 | 0.22 | +0.91% |
| Federated Hermes MDT Mid Cap Growth C | |||
| TRREX | 11.82 | -0.01 | -0.08% |
| T. Rowe Price Real Estate | |||
| SBHIX | 25.71 | -0.25 | -0.96% |
| Saratoga Health & Biotechnology I | |||